Bupivicaine to Reduce Postoperative Pain in Laparoscopic Ventral Hernia Repair



Status:Completed
Conditions:Post-Surgical Pain, Gastrointestinal
Therapuetic Areas:Gastroenterology, Musculoskeletal
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:August 2011
End Date:January 2013
Contact:Steve Chang, MD
Email:s1chang@sbch.org
Phone:805-637-0217

Use our guide to learn which trials are right for you!

Intraoperative Local Anesthesia for Management of Postoperative Pain Following Laparoscopic Ventral Hernia Repair: a Prospective Double-blind Randomized Trial

The investigators are testing to see if infusion of bupivicaine between the mesh and
abdominal wall can reduce postoperative pain and decrease use of narcotics in the
postoperative setting.

The primary objective of this study is to test different methods for pain management
following laparoscopic ventral hernia repair. We hypothesize that local analgesic injection
between the abdominal wall and mesh intraoperatively during laparoscopic ventral hernia
repair will result in a 20% decrease in the use of post-surgery pain medication in the first
four hours after surgery.

Inclusion Criteria:

1. Patient must be scheduled for a laparoscopic ventral hernia repair at SBCH. If any
additional procedure is performed, the subject will be excluded from the study

2. Age 18 or older

3. Patient must agree to complete pain journal postoperatively

4. Informed consent signed and dated by patient. Consenting through a legally authorized
guardian will not be accepted due to the necessity of completing a subjective pain
journal

Exclusion Criteria:

1. Any surgical procedure occurring besides the study procedure

2. Any allergy or sensitivity to bupivicaine or its derivatives

3. Less than 18 years of age

4. Patient unable to self report in pain journal due to cognitive disabilities

5. Discharged less than 4 hours post-surgery
We found this trial at
1
site
Santa Barbara, California 93105
?
mi
from
Santa Barbara, CA
Click here to add this to my saved trials